ETF DAILY NEWS

PVH (NYSE:PVH) Upgraded to Buy at Jefferies Financial G...

Jefferies Financial Group upgraded shares of PVH (NYSE:PVH – Free Report) from a...

Vanda Pharmaceuticals (NASDAQ:VNDA) Earns Overweight Ra...

Cantor Fitzgerald restated their overweight rating on shares of Vanda Pharmaceut...

International Business Machines (NYSE:IBM) Hits New 1-Y...

International Business Machines Co. (NYSE:IBM – Get Free Report)’s stock price h...

Salesforce (NYSE:CRM) Shares Down 0% Following Inside...

Salesforce, Inc. (NYSE:CRM – Get Free Report) shares dropped 0% on Thursday afte...

Gaotu Techedu (NYSE:GOTU) Shares Gap Up After Earnings...

Gaotu Techedu Inc. (NYSE:GOTU – Get Free Report) gapped up before the market ope...

Barclays Cuts Adaptimmune Therapeutics (NASDAQ:ADAP) Pr...

Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) had its target price reduce...

Abeona Therapeutics (NASDAQ:ABEO) Lowered to “Sell” Rat...

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) was downgraded by research a...

Affimed (NASDAQ:AFMD) Downgraded by HC Wainwright to Ne...

HC Wainwright downgraded shares of Affimed (NASDAQ:AFMD – Free Report) from a bu...

Allogene Therapeutics (NASDAQ:ALLO) Price Target Lowere...

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price cut by Op...

Absci’s (ABSI) Buy Rating Reiterated at Needham & Compa...

Needham & Company LLC reaffirmed their buy rating on shares of Absci (NASDAQ:ABS...

Astria Therapeutics (NASDAQ:ATXS) Receives Overweight R...

Cantor Fitzgerald reiterated their overweight rating on shares of Astria Therape...

Barclays Cuts Acadia Healthcare (NASDAQ:ACHC) Price Tar...

Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price target trimmed by Ba...

Needham & Company LLC Reaffirms Hold Rating for Airbnb ...

Needham & Company LLC restated their hold rating on shares of Airbnb (NASDAQ:ABN...

KeyCorp Cuts Acadia Healthcare (NASDAQ:ACHC) Price Targ...

Acadia Healthcare (NASDAQ:ACHC – Free Report) had its price target trimmed by Ke...

Robert W. Baird Lowers Allogene Therapeutics (NASDAQ:AL...

Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its price objective decrea...

Alumis (NASDAQ:ALMS) Price Target Cut to $25.00 by Anal...

Alumis (NASDAQ:ALMS – Get Free Report) had its price objective cut by equities r...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.